GlycoMimetics, Inc.
GLYC
$0.2417
-$0.033-12.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.86% | -1.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.10% | -44.76% | |||
| Operating Income | 7.10% | 44.76% | |||
| Income Before Tax | 26.48% | 2.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.48% | 2.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.48% | 2.69% | |||
| EBIT | 7.10% | 44.76% | |||
| EBITDA | 6.97% | 44.78% | |||
| EPS Basic | 26.51% | 2.68% | |||
| Normalized Basic EPS | 6.15% | 45.09% | |||
| EPS Diluted | 26.51% | 2.68% | |||
| Normalized Diluted EPS | 6.15% | 45.09% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||